CELL OF ORIGIN COMBINED WITH CNS INTERNATIONAL PROGNOSTIC INDEX IMPROVES IDENTIFICATION OF DLBCL PATIENTS WITH HIGH CNS RELAPSE RISK AFTER INITIAL IMMUNOCHEMOTHERAPY

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

CNS involvement in DLBCL.

A 70-year-old woman presented with 4 weeks of progressive bilateral lower extremity weakness. She had past medical history of stage III diffuse large B-cell lymphoma treated with 6 cycles of R-CHOP chemotherapy, which was completed 6 months prior to presentation. All risk factors for central nervous system (CNS) relapse were negative except for thickening of left paranasal sinus. A computed tom...

متن کامل

How I treat patients with aggressive lymphoma at high risk of CNS relapse.

Central nervous system (CNS) relapses are an uncommon yet devastating complication of non-Hodgkin lymphomas. The identification of patients at high risk of secondary CNS relapse is therefore paramount. Retrospective data indicate prophylactic CNS-directed therapies may reduce the risk of CNS involvement; however, no consensus exists about dose, timing, or route of therapy. In addition, prophyla...

متن کامل

Comparison of CNS Relapse, Survival and Intelligent Quotient in Non-High Risk ALL Children Treated with Intrathecal Methotrexate or Triple Intrathecal Therapy

Background Compared to intrathecal methotrexate (IT MTX), triple intrathecal therapy (TIT) has shown promising results in decr...

متن کامل

Relapse pattern and prognostic factors for patients with primary CNS lymphoma

Age Median (Range) 59 (28-76) 53 (33-65) 0.260 Age 0.253 ≥60 20 (47.6%) 5 (27.8%) <60 22 (52.4%) 13 (72.2%) Gender 0.241 Male 25 (59.5%) 14 (77.8%) Female 17 (40.5%) 4 (22.2%) Involvement sites 1.000 Intracranial lesion only 38 (90.5%) 15 (83.3%) Extracranial involvement 6 3 Leptomeningeal seeding 4 2 Ocular lesion 1 1 Spinal cord 1 0 B Symptom 1.000 Yes 1 (2.4%) 0 (0.0%) No 41 (97.6%) 18 (100....

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Hematological Oncology

سال: 2017

ISSN: 0278-0232

DOI: 10.1002/hon.2437_25